Neuphoria Therapeutics Inc. SEC filings NEUP

Neuphoria Therapeutics Inc. has 420 filings in SEC EDGAR's recent list, going back to Sep 11, 2002. Its latest annual report, Form 10-K, was filed on Sep 18, 2026 for the period ended Jun 30, 2026. The latest quarterly report (Form 10-Q) was filed on May 15, 2026, covering the quarter ended Mar 31, 2026. The most recent current report (Form 8-K) was filed on Oct 23, 2026 (material agreement, change to shareholder rights). The company's fiscal year ends on June 30.

Form Description Filed Period
10-K Annual report Sep 18, 2026 Jun 30, 2026
10-K Annual report Sep 29, 2025 Jun 30, 2025
10-K Annual report Sep 30, 2024 Jun 30, 2024
20-F/A Amended annual report (foreign issuer) Jan 17, 2024 Jun 30, 2023
20-F Annual report (foreign issuer) Oct 18, 2023 Jun 30, 2023
20-F Annual report (foreign issuer) Oct 14, 2022 Jun 30, 2022
ARS Annual report to shareholders Jul 23, 2008 Jun 30, 2007
ARS Annual report to shareholders Aug 29, 2005 Jun 30, 2005
ARS Annual report to shareholders Sep 13, 2004 Jun 30, 2004
ARS Annual report to shareholders Jan 15, 2004 Jun 30, 2003
ARS Annual report to shareholders Oct 21, 2002 Jun 30, 2002
ARS Annual report to shareholders Sep 11, 2002 Jun 30, 2001

Showing 12 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
NEUP (Nasdaq)
Fiscal year ends
June 30
Incorporated in
Australia
Headquarters
Burlington, MA
SEC filer status
Non-accelerated filer, Smaller reporting company, Emerging growth company
SEC CIK
1191070
Former names
BIONOMICS LIMITED/FI (until Dec 23, 2024)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.